Get the Stockscreener App
3.07
0.33%
0.010
After Hours:
3.04
-0.03
-0.98%
Sera Prognostics Inc stock is traded at $3.07, with a volume of 8,568.
It is up +0.33% in the last 24 hours and down -0.97% over the past month.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
See More
Previous Close:
$3.06
Open:
$3.1
24h Volume:
8,568
Relative Volume:
0.10
Market Cap:
$112.68M
Revenue:
$306.00K
Net Income/Loss:
$-36.24M
P/E Ratio:
-2.6466
EPS:
-1.16
Net Cash Flow:
$-27.32M
1W Performance:
-5.83%
1M Performance:
-0.97%
6M Performance:
-5.54%
1Y Performance:
-56.14%
1-Day Range:
$2.90
$3.10
1-Week Range:
$2.90
$3.292
52-Week Range:
$1.37
$9.1297
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
3.07 | 116.47M | 306.00K | -36.24M | -27.32M | -1.16 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | Oppenheimer | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
Is Sera Prognostics Inc. forming a reversal patternJuly 2025 Breakouts & AI Based Trade Execution Alerts - newser.com
What indicators show strength in Sera Prognostics Inc.July 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
Signal strength of Sera Prognostics Inc. stock in tech scannersWeekly Trade Summary & Weekly High Return Forecasts - newser.com
Will Sera Prognostics Inc. stock outperform Dow Jones index2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Should you hold or exit Sera Prognostics Inc. nowQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
How to use Fibonacci retracement on Sera Prognostics Inc.July 2025 Price Swings & High Conviction Trade Alerts - newser.com
Candlestick signals on Sera Prognostics Inc. stock todayMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Is Sera Prognostics Inc. stock cheap at current valuationPortfolio Performance Report & Accurate Technical Buy Alerts - newser.com
Pattern recognition hints at Sera Prognostics Inc. upsideBreakout Watch & Capital Efficient Trade Techniques - newser.com
How buybacks impact Sera Prognostics Inc. stock valueJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
What drives Sera Prognostics Inc stock priceBull Market Opportunities & Minimal Capital Growth Plans - earlytimes.in
Sera Prognostics (NASDAQ:SERA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Will Sera Prognostics Inc. continue its uptrendQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-09 02:25:33 - newser.com
Published on: 2025-10-09 05:14:41 - earlytimes.in
Insider Sell: Robert Harrison Sells 2,000 Shares of Sera Prognos - GuruFocus
Sera prognostics CIO Harrison sells $6360 in stock By Investing.com - Investing.com Canada
What analysts say about Sera Prognostics Inc stockValue Stock Picks & High Profit Trading Signals - earlytimes.in
Sera Prognostics Inc Stock Analysis and ForecastMerger & Acquisition Updates & Big Gains Small Investment - earlytimes.in
Identifying reversal signals in Sera Prognostics Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - newser.com
What Fibonacci levels say about Sera Prognostics Inc. reboundTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Will a bounce in Sera Prognostics Inc. offer an exitPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Should you wait for a breakout in Sera Prognostics Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Tools to assess Sera Prognostics Inc.’s risk profileWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer By Investing.com - Investing.com Nigeria
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer - Investing.com
Women's Health Pioneer Sera Prognostics Taps OBGYN Leader Dr. Inglis to Drive PreTRM Test Adoption - Stock Titan
Detecting support and resistance levels for Sera Prognostics Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):